Understanding Stem Cell Transplant in Myeloma

The IMF’s Understanding Stem Cell Transplant in Myeloma publication is intended for myeloma patients in the United States who are in discussions with their treating doctors about the possibility of having an autologous stem cell transplant (ASCT) as part of their overall treatment strategy. This booklet describes the typical journey of a patient with myeloma in the U.S. who might undergo ASCT.